Quetiapine Fumarate Tablet, Film Coated
Product Images NDC 16714-377

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Quetiapine Fumarate (NDC 16714-377). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Quetiapine Fig1)

A Kaplan-Meier curve graph showing the time to recurrence of a mood event in weeks for two groups: QTP+LI/VAL and PLA+LI/VAL. The y-axis represents the proportion of patients with relapse (%) up to 100%, and the x-axis represents time in weeks up to 100 weeks. The QTP+LI/VAL group shows a higher relapse proportion compared to the PLA+LI/VAL group over time.*

FDA Label Image

Figure2 (Quetiapine Fig2)

A Kaplan-Meier curve graph depicting the proportion of patients with relapse (%) over time (weeks). Two treatment groups are shown: QTP+LI/VAL and PLA+LI/VAL, with relapse proportion increasing over 100 weeks. The graph demonstrates changes in relapse rates across time for each group in a mood event study.*

FDA Label Image

Package Label-principal Display Panel (25 mg (100 Tablets Bottle))

Quetiapine Fumarate 25 mg film-coated tablets label showing product name, strength, and quantity (100 tablets). The label includes the NDC 16714-375-01, manufacturer NorthStar Rx LLC, and directions to dispense with medication guide. It provides storage instructions and warnings, plus manufacturing details including Aurobindo Pharma Limited, India. Bar code is present on the right side.*

FDA Label Image

Package Label-principal Display Panel (50 mg (100 Tablets Bottle))

Packaging label for Quetiapine Tablets USP 50 mg, film-coated oral tablets containing quetiapine fumarate. The label states a package size of 100 tablets and identifies NorthStar Rx LLC as the labeler, with manufacturing by Aurobindo Pharma Limited in India. The label includes storage instructions, a warning to keep out of reach of children, and a pharmacist dispensing notice. The NDC is 16714-376-01.*

FDA Label Image

Package Label-principal Display Panel (100 mg (100 Tablets Bottle))

Label for Quetiapine Tablets, USP 100 mg film-coated tablets by NorthStar Rx LLC. The label shows the NDC code 16714-377-01, package of 100 tablets, and manufacturer information including Aurobindo Pharma Limited, India. It includes storage instructions, warnings, and contact details for medication guides.*

FDA Label Image

Package Label-principal Display Panel (200 mg (100 Tablets Bottle))

Quetiapine Tablets USP 200 mg film-coated tablets label, displaying the strength, quantity of 100 tablets, and manufacturer information including NorthStar Rx LLC and Aurobindo Pharma Limited. The label includes storage instructions, active ingredient amount, NDC 16714-378-01, and warnings for pharmacist and consumers.*

FDA Label Image

Package Label-principal Display Panel (300 mg (100 Tablets Bottle))

Label for Quetiapine Tablets USP 300 mg film-coated oral tablets in a 100-count package. The label includes storage instructions, dosage reference, and manufacturer information, showing NorthStar Rx LLC as the labeler and Aurobindo Pharma Limited as the manufacturer.*

FDA Label Image

Package Label-principal Display Panel (400 mg (100 Tablets Bottle))

Quetiapine Tablets, USP 400 mg film-coated tablet label displaying NDC 16714-380-01. The label states the package contains 100 tablets and includes storage instructions, manufacturer details (Northstar Rx LLC and Aurobindo Pharma Limited), and a warning to dispense with a medication guide. The label features NorthStar Rx branding in blue and black text on a white background.*

FDA Label Image

Chemical Structure (Quetiapine Str)

Chemical structure of Quetiapine Fumarate, showing the molecular arrangement including its two-part structure with a piperazine ring and a thienobenzodiazepine moiety alongside the fumarate component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.